At a time when the Covid second wave is raging, a Mysuru-based company has developed a new set of drugs to combat the Coronavirus, and the advantage is that these drugs can be administered orally. DRM Innovations, has used artificial intelligence to develop the drug. A team of specialists, led by Dr Manjunath B H, MD of DRM,
Dr Basappa, Chairman, Laboratory of Chemical Biology, Department of Studies in Organic Chemistry, University of Mysore, and Prof Mahesh PA, Department of Respiratory Medicine, JSS Medical College and Hospital, has developed the drugs.